120 related articles for article (PubMed ID: 4009512)
21. Leishmania tropica: surface antigens of intracellular and flagellate forms.
Handman E; Curtis JM
Exp Parasitol; 1982 Oct; 54(2):243-9. PubMed ID: 7128719
[No Abstract] [Full Text] [Related]
22. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
Karp CL; Turco SJ; Sacks DL
J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani donovani antigens recognized by kala-azar patient sera and identification of cross-reacting antigens to Chagas' disease.
Andrade CR; Andrade PP; Wright EP
Braz J Med Biol Res; 1988; 21(3):511-5. PubMed ID: 3147797
[TBL] [Abstract][Full Text] [Related]
24. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
Sacks DL; Hieny S; Sher A
J Immunol; 1985 Jul; 135(1):564-9. PubMed ID: 2582050
[TBL] [Abstract][Full Text] [Related]
25. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi.
dos Santos JI; Morgado MG; Galvão-Castro B
Am J Trop Med Hyg; 1987 Sep; 37(2):263-70. PubMed ID: 2444121
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
[TBL] [Abstract][Full Text] [Related]
27. Leishmania donovani: isolation of a concanavalin-A specific antigen and its evaluation for serodiagnosis of visceral leishmaniasis.
Bhattacharya M; Banerjee N; Ghosh DK
Ann Trop Med Parasitol; 1992 Aug; 86(4):341-5. PubMed ID: 1281399
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies against leishmanial membranes react with specific excreted factors (EF).
Schnur LF; Sarfstein R; Jaffe CL
Ann Trop Med Parasitol; 1990 Oct; 84(5):447-56. PubMed ID: 1701624
[TBL] [Abstract][Full Text] [Related]
29. A direct agglutination test for leishmaniasis.
Allain DS; Kagan IG
Am J Trop Med Hyg; 1975 Mar; 24(2):232-6. PubMed ID: 804268
[TBL] [Abstract][Full Text] [Related]
30. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
[TBL] [Abstract][Full Text] [Related]
31. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
Sinha R; Arora SK; Datta U; Sehgal S
Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
[TBL] [Abstract][Full Text] [Related]
32. Surface antigens of Leishmania donovani promastigotes.
Lepay DA; Nogueira N; Cohn Z
J Exp Med; 1983 May; 157(5):1562-72. PubMed ID: 6854205
[TBL] [Abstract][Full Text] [Related]
33. ELISA using intact promastigotes for immunodiagnosis of kala-azar.
Mohammed EA; Wright EP; Kager PA; Laarman JJ; Pondman KW
Trans R Soc Trop Med Hyg; 1985; 79(3):344-50. PubMed ID: 4035734
[TBL] [Abstract][Full Text] [Related]
34. Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients.
Kamoun-Essghaier S; Guizani I; Strub JM; Van Dorsselaer A; Mabrouk K; Ouelhazi L; Dellagi K
Clin Diagn Lab Immunol; 2005 Feb; 12(2):310-20. PubMed ID: 15699427
[TBL] [Abstract][Full Text] [Related]
35. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with Leishmania donovani.
Bimal S; Bagchi AK; Das V; Sinha PK; Lal CS; Ranjan A; Gupta AK; Kar SK
Indian J Exp Biol; 2001 Sep; 39(9):878-82. PubMed ID: 11831368
[TBL] [Abstract][Full Text] [Related]
36. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I
J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
[TBL] [Abstract][Full Text] [Related]
37. Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
Theinert SM; Basu R; Forgber M; Roy S; Sundar S; Walden P
Infect Immun; 2005 Oct; 73(10):7018-21. PubMed ID: 16177384
[TBL] [Abstract][Full Text] [Related]
38. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
39. A comparison of enzyme-linked immunosorbent assay and indirect fluorescent antibody test in the sero-diagnosis of cutaneous and visceral leishmaniasis in Iran.
Edrissian GH; Darabian P
Trans R Soc Trop Med Hyg; 1979; 73(3):289-92. PubMed ID: 382470
[TBL] [Abstract][Full Text] [Related]
40. ELISA titres to polysaccharide antigens of Leishmania donovani promastigotes in kala-azar.
Ray R; Ghose AC
Trans R Soc Trop Med Hyg; 1986; 80(6):998. PubMed ID: 3603654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
